Causes and Management of Hot Flashes
Primary Causes
- Menopause and hormonal changes are the most common cause of hot flashes, triggered by hormonal fluctuation during perimenopause and menopause 1, 2
- Cancer treatments, including endocrine therapies for breast cancer, chemotherapy-induced ovarian dysfunction, and surgical menopause, can trigger hot flashes 3, 4
- Discontinuation of hormone replacement therapy often produces recurrence of menopausal symptoms, including hot flashes 3
Environmental and Lifestyle Triggers
- Dietary triggers, such as spicy foods, alcohol, and caffeine, can trigger or worsen hot flashes 2, 4
- Environmental heat, hot environments, hairdryers, and overheating can precipitate hot flashes 1, 2
- Smoking may be associated with more severe hot flashes 1, 2
- Obesity is associated with more severe hot flashes 1, 2
- Stress and anxiety can precipitate hot flashes 2
Management Approaches
- Lifestyle modifications, such as dressing in layers, avoiding overheating, using natural fibers, and applying cold packs, can help manage hot flashes 1, 2
- Identifying triggers through a hot flash diary can help modify symptoms 1, 2
- Non-hormonal medications, including SNRIs, SSRIs, gabapentin, and clonidine, have shown efficacy in reducing hot flashes 5, 6, 7
- Acupuncture has shown benefit in reducing menopausal symptoms, including hot flashes 4, 8
- Cognitive behavioral therapy, hypnosis, and relaxation techniques may help manage hot flashes 8
- Environmental modifications, such as maintaining cool room temperatures, can help manage hot flashes 4
Management of Hot Flashes
Pharmacological Options
- Vitamin E (800 IU/day) may provide modest relief for mild hot flash symptoms, according to the American Society of Clinical Oncology 9
- Clonidine has shown some efficacy in reducing hot flash severity, but its use is limited due to side effects like dry mouth, constipation, and drowsiness, as noted by the National Comprehensive Cancer Network 10
Considerations for Treatment
- The decision to intervene should consider the efficacy and toxicity of the intervention, as suggested by the National Comprehensive Cancer Network 10
- High-dose vitamin E (>400 IU/day) has been linked with an increase in all-cause mortality and should be used with caution, as reported in Annals of Oncology, and guided by societies such as the American College of Physicians 9
Hot Flashes in Older Women
Clinical Context and Causes
- Cancer treatment-related causes, particularly in patients with a history of breast cancer treatment with endocrine therapy, can cause severe and prolonged vasomotor symptoms, according to the National Comprehensive Cancer Network 11
- It is essential to rule out secondary medical causes, including thyroid disease and diabetes, which should be assessed in any patient with vasomotor symptoms, as recommended by the National Comprehensive Cancer Network 12
Management Approach
- Nonhormonal options should be the first-line therapy for an 84-year-old woman with bothersome hot flashes, according to the National Comprehensive Cancer Network 12
- Gabapentin has shown efficacy in reducing vasomotor symptoms in cancer survivors and postmenopausal women, as reported by the National Comprehensive Cancer Network 12
- Low-dose SSRIs, such as paroxetine 7.5 mg daily, can reduce the frequency and severity of hot flashes, as recommended by the National Comprehensive Cancer Network 12
Common Pitfalls to Avoid
- Hot flashes should not be assumed to be "normal for age" and dismissed, as they can significantly impact quality of life and warrant treatment, according to the Annals of Oncology 11
- The possibility of cancer treatment-related causes should not be overlooked, particularly in women with a history of breast cancer, who may experience severe and prolonged symptoms, as reported by the Annals of Oncology 11
Hot Flashes in Women
Primary Physiological Causes
- Natural menopause represents the predominant cause, with hot flashes occurring in approximately 69% of untreated postmenopausal women 13
Cancer Treatment-Related Causes
- Selective estrogen receptor modulators (SERMs): Tamoxifen causes hot flashes in approximately 81% of treated women compared to 69% on placebo, while raloxifene also increases vasomotor symptoms 14, 13
Management of Hot Flashes in Patients
Pharmacologic Options
- The American College of Rheumatology recommends menopausal hormone therapy, which reduces hot flashes by approximately 75%, but should be reserved for severe cases unresponsive to nonhormonal options and used only at the lowest effective dose for the shortest duration (not more than 3-5 years) 15
Contraindications for Hormone Therapy
- The Arthritis Care & Research guideline society lists contraindications for hormone therapy, including history of breast cancer, coronary heart disease, previous venous thromboembolism, stroke, active liver disease, or antiphospholipid syndrome 15